Download PDF
Semin Respir Crit Care Med 2003; 24(6): 619-628
DOI: 10.1055/s-2004-815658
PREFACE

Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Overview of Cystic Fibrosis and Non-CF Bronchiectasis

Bruce K. Rubin
  • Pediatrics, and Biomedical Engineering, Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Further Information

Publication History

Publication Date:
15 January 2004 (online)

    Permissions and Reprints

This issue of Seminars in Respiratory and Critical Care Medicine is devoted to the diagnosis and management of cystic fibrosis (CF) and selected forms of non-CF bronchiectasis. Because airway inflammation and destruction are strongly related to chronic infection, about half of this issue focuses on the microbiology of these diseases, and prevention and therapy of bronchial infections. This Preface and Overview presents the clinical context for the development of this issue of SRCCM. [[author photo]]

REFERENCES

  • 1 Barker A F, Bardana Jr E J. Bronchiectasis: Update of an orphan disease.  Am Rev Respir Dis . 1988;  137 969-978
    PubMedGoogle Scholar
  • 2 Stanford W, Galvin J R. The diagnosis of bronchiectasis.  Clin Chest Med . 1988;  9 691-699
    PubMedGoogle Scholar
  • 3 Pang J A, Hamilton-Wood C, Metreweli C. The value of computed tomography in the diagnosis and management of bronchiectasis.  Clin Radiol . 1989;  40 40-44
    CrossrefPubMedGoogle Scholar
  • 4 Verra F, Escudier E, Bignon J. et al . Inherited factors in diffuse bronchiectasis in the adult: a prospective study.  Eur Respir J . 1991;  4 937-944
    PubMedGoogle Scholar
  • 5 Leigh M W. Primary ciliary dyskinesia.  Semin Respir Crit Care Med . 2003;  24 653-662
    PubMedGoogle Scholar
  • 6 Bush A, Rubin B K. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis.  Semin Respir Crit Care Med . 2003;  24 737-748
    PubMedGoogle Scholar
  • 7 Wilson J F, Decker A M. The surgical management of childhood bronchiectasis.  Ann Surg . 1982;  195 354-363
    PubMedGoogle Scholar
  • 8 Davis P B, Drumm M, Konstan M W. State of the art: cystic fibrosis.  Am J Respir Crit Care Med . 1996;  154 1229-1256
    PubMedGoogle Scholar
  • 9 Gallati S. Genetics of cystic fibrosis.  Semin Respir Crit Care Med . 2003;  24 629-638
    PubMedGoogle Scholar
  • 10 Rosenstein B J. Cystic fibrosis. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children: Diagnosis and Management 1st ed. Baltimore: Williams & Wilkins 1994: 263-289
    Google Scholar
  • 11 Ramsey B W, Farrell P M, Pencharz P. et al . Nutritional assessment and management in cystic fibrosis: a consensus report.  Am J Clin Nutr . 1992;  55 108-116
    PubMedGoogle Scholar
  • 12 Currie A J, Speert D P, Davidson D J. Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion.  Semin Respir Crit Care Med . 2003;  24 671-680
    PubMedGoogle Scholar
  • 13 Jackson K, Kayser R, Wozniak D J. The role of biofilms in airway disease.  Semin Respir Crit Care Med . 2003;  24 663-670
    PubMedGoogle Scholar
  • 14 Sexauer W P, Fiel S B. Aerosolized antibiotics in cystic fibrosis.  Semin Respir Crit Care Med . 2003;  24 717-726
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Nick J A. Nontuberculous mycobacteria in cystic fibrosis.  Semin Respir Crit Care Med . 2003;  24 693-702
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 LiPuma J J. Burkholderia and emerging pathogens in cystic fibrosis.  Semin Respir Crit Care Med . 2003;  24 681-692
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Frederiksen B, Koch C, Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.  Pediatr Pulmonol . 1997;  23 330-335
    CrossrefPubMedGoogle Scholar
  • 18 Koch C, Frederiksen B, Høiby N. Patient cohorting and infection control.  Semin Respir Crit Care Med . 2003;  24 703-716
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Konstan M W, Byard P J, Hoppel C L, Davis P B. Effect of high-dose ibuprofen in patients with cystic fibrosis.  N Engl J Med . 1995;  332 848-854
    CrossrefPubMedGoogle Scholar
  • 20 van der Schans P C, de Jong W, Rubin B K. Chest physical therapy: Assessment of techniques.  Clin Pulm Med . 1996;  3 179-184
    PubMedGoogle Scholar
  • 21 Flume P A. Airway clearance techniques.  Semin Respir Crit Care Med . 2003;  24 727-736
    PubMedGoogle Scholar
  • 22 Ramsey B W, Astley S J, Aitken M L. et al . Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis.  N Engl J Med . 1994;  331 637-642
    CrossrefPubMedGoogle Scholar
  • 23 Rubin B K. Cystic fibrosis: bench to bedside 2003.  Can Respir J . 2003;  10 161-164
    PubMedGoogle Scholar
  • 24 Sweet S C, Spray T L, Huddleston C B. et al . Pediatric lung transplantation at St Louis Children's Hospital, 1990-1995.  Am J Respir Crit Care Med . 1997;  155 1027-1035
    CrossrefPubMedGoogle Scholar
  • 25 Weiss D J, Pilewski J M. The status of gene therapy for cystic fibrosis.  Semin Respir Crit Care Med . 2003;  24 749-770
    PubMedGoogle Scholar
  • 26 Schechter M S. Nongenetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and health care interventions.  Semin Respir Crit Care Med . 2003;  24 639-652
    Article in Thieme ConnectPubMedGoogle Scholar
      >